The Complex Interplay Between Cholesterol and Prostate Malignancy

被引：61
作者：
Solomon, Keith R. [1 ]
Freeman, Michael R. [2 ,3 ]
机构：
[1] Harvard Univ, Sch Med, Childrens Hosp Boston,Dept Orthopaed Surg, Enders Res Labs,Urol Dis Res Ctr, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Childrens Hosp Boston, Enders Res Labs,Dept Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
来源：
UROLOGIC CLINICS OF NORTH AMERICA | 2011年 / 38卷 / 03期
关键词：
Prostate cancer; Cholesterol; Statins; Steroidogenesis; Castration resistance; CORONARY-HEART-DISEASE; ANDROGEN DEPRIVATION THERAPY; SCANDINAVIAN SIMVASTATIN SURVIVAL; RENAL-TRANSPLANT RECIPIENTS; TOTAL SERUM-CHOLESTEROL; INTIMA-MEDIA THICKNESS; LOW BLOOD CHOLESTEROL; 10-YEAR FOLLOW-UP; I CLINICAL-TRIAL; CANCER-MORTALITY;
D O I：
10.1016/j.ucl.2011.04.001
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Research into the role of cholesterol and prostate disease has been ongoing for many years, but our mechanistic and translational understanding is still poor. Recent evidence indicates that cholesterol-lowering drugs reduce the risk of aggressive prostate cancer. This article reviews the literature on the relationship between circulating cholesterol and prostate cancer. The data strongly point to hypercholesterolemia as a risk factor for prostate cancer progression and suggest clinical opportunities for the use of cholesterol-lowering therapies to alter disease course.
引用
收藏
页码：243 / +
页数：18
相关论文
共 188 条
  • [1] Cholesterol sensitivity of endogenous and myristoylated Akt
    Adam, Rosalyn M.
    Mukhopadhyay, Nishit K.
    Kim, Jayoung
    Di Vizio, Dolores
    Cinar, Bekir
    Boucher, Kelly
    Solomon, Keith R.
    Freeman, Michael R.
    [J]. CANCER RESEARCH, 2007, 67 (13) : 6238 - 6246
  • [2] Inhibition of acyl-coenzyme A:cholesterol acyltransferase stimulates cholesterol efflux from macrophages and stimulates farnesoid X receptor in hepatocytes
    An, Sojin
    Jang, Young-Soon
    Park, Ji-Seon
    Kwon, Byoung-Mog
    Paik, Young-Ki
    Jeong, Tae-Sook
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2008, 40 (04) : 407 - 417
  • [3] CHOLESTEROL AND MORTALITY - 30 YEARS OF FOLLOW-UP FROM THE FRAMINGHAM-STUDY
    ANDERSON, KM
    CASTELLI, WP
    LEVY, D
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (16): : 2176 - 2180
  • [4] CYP17 blockade by abiraterone: further evidence for frequent continued hormone-dependence in castration-resistant prostate cancer
    Ang, Je
    Olmos, D.
    de Bono, J. S.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (05) : 671 - 675
  • [5] [Anonymous], 2000, Ital Heart J, V1, P810
  • [6] [Anonymous], 1993, Am J Cardiol, V72, P1031
  • [7] [Anonymous], J CLIN ONCOL S7
  • [8] Is abiraterone acetate well tolerated and effective in the treatment of castration-resistant prostate cancer?
    Antonarakis, Emmanuel S.
    Eisenberger, Mario A.
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2009, 6 (01): : 12 - 13
  • [9] The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]
    Armitage, Jane
    Collins, Rory
    Bowman, Louise
    Parish, Sarah
    Sleight, Peter
    Peto, Richard
    Meade, T.
    Youngman, L.
    Buxton, M.
    de Bono, D.
    George, C.
    Fuller, J.
    Keech, A.
    Mansfield, A.
    Pentecost, B.
    Simpson, D.
    Warlow, C.
    McNamara, J.
    O'Toole, L.
    Doll, R.
    Wilhelmsen, L.
    Fox, K. M.
    Hill, C.
    Sandercock, P.
    [J]. BMC MEDICINE, 2005, 3 (1)
  • [10] Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
    Attard, Gerhardt
    Reid, Alison H. M.
    Yap, Timothy A.
    Raynaud, Florence
    Dowsett, Mitch
    Settatree, Sarah
    Barrett, Mary
    Parker, Christopher
    Martins, Vanessa
    Folkerd, Elizabeth
    Clark, Jeremy
    Cooper, Colin S.
    Kaye, Stan B.
    Dearnaley, David
    Lee, Gloria
    de Bono, Johann S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) : 4563 - 4571
12345678910